SIRT3 Overexpression Attenuates Palmitate-Induced Pancreatic β-Cell Dysfunction

Area of Science:

• Endocrinology
• Molecular Biology
• Metabolic Diseases

Background:

• High circulating free fatty acids impair pancreatic beta-cell function and survival, contributing to Type 2 diabetes.
• Sirtuin-3 (SIRT3), an NAD+-dependent deacetylase, is linked to Type 2 diabetes pathogenesis.

Purpose of the Study:

• To investigate the protective effects of SIRT3 overexpression against palmitate-induced beta-cell dysfunction in mouse pancreatic beta-cell line NIT1.

Main Methods:

• Overexpression of full-length (SIRT3LF) and truncated (SIRT3SF) SIRT3 using an adenoviral system in NIT1 cells.
• Assessment of cell viability, mitogen-activated protein kinase (MAPK) activation, and glucose-stimulated insulin secretion (GSIS) under palmitate exposure.
• Analysis of endoplasmic reticulum (ER) stress marker gene expression (ATF4, GRP94, FKBP11).

Main Results:

• SIRT3LF and SIRT3SF overexpression mitigated palmitate-induced lipotoxicity, including reduced cell viability and MAPK activation.
• Overexpression of both SIRT3 forms reversed palmitate-induced suppression of GSIS.
• SIRT3LF overexpression completely inhibited palmitate-induced upregulation of ER stress genes, while SIRT3SF showed a lesser effect.

Conclusions:

• SIRT3 overexpression alleviates palmitate-induced beta-cell dysfunction and lipotoxicity.
• SIRT3 plays a protective role against ER stress induced by free fatty acids in pancreatic beta cells.
• Targeting SIRT3 may represent a therapeutic avenue for managing Type 2 diabetes.